Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters

We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stab...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 44; no. 7; p. 115907
Main Authors da Silva Antunes, Ricardo, Fajardo-Rosas, Vicente, Yu, Esther Dawen, Gálvez, Rosa Isela, Abawi, Adam, Escarrega, E. Alexandar, Martínez-Pérez, Amparo, Johansson, Emil, Goodwin, Benjamin, Frazier, April, Dan, Jennifer M., Crotty, Shane, Seumois, Grégory, Weiskopf, Daniela, Vijayanand, Pandurangan, Sette, Alessandro
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 22.07.2025
Elsevier
Subjects
Online AccessGet full text
ISSN2211-1247
2211-1247
DOI10.1016/j.celrep.2025.115907

Cover

More Information
Summary:We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stabilize with each booster, T cell responses quickly plateau and remain stable. Notably, approximately 30% of participants show evidence suggestive of asymptomatic infections. Single-cell RNA sequencing reveals a diverse and stable landscape of spike-specific T cell phenotypes without signs of exhaustion or functional impairment. Individuals with evidence of asymptomatic infection display increased frequencies of Th17-like CD4+ T cells and GZMKhi/IFNR+ CD8+ T cell subsets. In this group, repeated vaccinations correlate with an increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections. [Display omitted] •≈30% of participants show evidence of asymptomatic infections despite no symptoms•Antibody levels increase with each booster; T cell responses plateau early and stabilize•Single-cell analysis reveals stable T cell phenotypes without exhaustion after boosters•Asymptomatic cases develop more regulatory T cells, potentially preventing pathology da Silva Antunes et al. examine SARS-CoV-2-specific immunity across 3 years of repeated vaccinations. While antibodies increase with each booster, T cells responses plateau early and remain stable without signs of exhaustion or functional impairment. Asymptomatic infections promote Th17-like and regulatory CD4+ T cell expansion, suggesting balanced immunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2025.115907